Cargando…
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Subcutaneous MYL1501D insulin glargine 100 U/mL (hereafter referred to as MYL1501D insulin glargine) [Semglee(®)] is a long-acting human insulin analogue approved as a biosimilar of insulin glargine 100 U/mL (hereafter referred to as reference insulin glargine 100 U/mL) [Lantus(®)] in various countr...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217807/ https://www.ncbi.nlm.nih.gov/pubmed/32215829 http://dx.doi.org/10.1007/s40259-020-00418-x |